Positive results for early macular degeneration with laser therapy

University of Melbourne researchers published the results of their latest study in The FASEB Journal. This study evaluated the effectiveness of the new nanosecond laser in treating patients with early age-related macular degeneration. This revolutionary laser is low-impact and low-energy. What researchers found is that unlike current laser therapies,¬† the nanosecond laser does not damage the retina. In addition, initial results showed that the nanosecond laser slows progression of macular degeneration and may even reverse it. Another benefit of the treatment is that treating one eye can have positive results in the untreated eye. This means that it's possible that only one treatment may be needed to successfully treat both eyes. While additional studies and testing will be required, researchers are encouraged by these initial findings.*